DNA methylation and cervical cancer risk study
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This study looks at DNA methylation (a chemical change in your DNA) in women with abnormal HPV or Pap test results to see if it can help predict who might develop cervical cancer. It may help guide future screening and prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old and have been sexually active.
- You have had both an HPV test and a Pap (TCT) test at the same time.
- Your HPV or Pap test results were abnormal, and you had a follow-up tissue biopsy.
- You are not pregnant or breastfeeding.
- You do not have an immune disorder like AIDS or lupus (SLE).
- You have not had surgery on your cervix (like LEEP or cone biopsy) in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new DNA-based method to screen for cervical cancer using a sample of cells from the cervix. It aims to find cancer earlier and more accurately than current methods.
This study is testing a new, non-invasive way to screen for cervical cancer. It uses a photoelectric device and an epigenetic test done on a sample from your cervix. The goal is to find early signs of cancer more accurately than current methods.
This study looks at whether certain markers in your blood (DNA from cancer cells and HPV) can help predict how well you do after first treatment for cervical cancer that has come back or spread. You would have extra blood draws during follow-up visits.
This study looks at whether selenium levels in your body are linked to HPV and cervical changes. It may help us understand how to better prevent or treat cervical issues.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.